Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.

Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis. Cancer. 1994 May 01; 73(9):2408-16.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
beta 2-Microglobulin
Bleomycin
Combined Modality Therapy
Cyclophosphamide
Dexamethasone
Doxorubicin
Etoposide
Female
Follow-Up Studies
Humans
L-Lactate Dehydrogenase
Lymphoma, Non-Hodgkin
Male
Methotrexate
Middle Aged
Prednisone
Prognosis
Radiotherapy Dosage
Remission Induction
Survival Rate
Vincristine

authors with profiles

FREDRICK B HAGEMEISTER
MARIA A RODRIGUEZ